Literature DB >> 23982208

Efficacy of bispectral index monitoring during balanced propofol sedation for colonoscopy: a prospective, randomized controlled trial.

Yeon Hwa Yu1, Dong Soo Han, Hyun Soo Kim, Eun Kyung Kim, Chang Soo Eun, Kyo-Sang Yoo, Woo Jong Shin, Seungho Ryu.   

Abstract

BACKGROUND AND AIMS: Appropriate use of propofol is necessary, and objective monitoring of sedation with propofol may be helpful. Studies on the efficacy of bispectral index (BIS) monitoring in deep sedation have been conducted, but its efficacy in colonoscopy with moderate sedation is unknown. In this study, the efficacy of BIS monitoring during colonoscopy with moderate level sedation via balanced propofol sedation was investigated.
METHODS: To determine the cut-off value of BIS before the test, an optimal BIS value was determined. Patients who were scheduled to undergo outpatient colonoscopy were prospectively randomized to either a BIS or control group. Finally, a total of 115 patients were selected for this study. The satisfaction level, the complication, and the dosage of the administered propofol were compared.
RESULTS: The BIS values and the modified observer's assessment of alertness/sedation scores (MOAA/S) were positively correlated (r=0.66 and p<0.001). The optimal cut-off value of BIS for maintaining moderate sedation was 81, and the area under the ROC curve was 0.88 (95% CI 0.82-0.93), indicating high prediction accuracy. However, there was no difference between the BIS group and the control group in levels of satisfaction of either patients or endoscopists. In addition, there was no difference in the complication and the required dose of propofol between both groups.
CONCLUSIONS: BIS and clinical sedation scores, MOAA/S scores, showed a high level of correlation. However, no significant efficacy was observed in the BIS group who underwent outpatient colonoscopy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23982208     DOI: 10.1007/s10620-013-2833-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Bispectral index monitoring of sedation during endoscopy.

Authors:  A L Bower; A Ripepi; J Dilger; N Boparai; F J Brody; J L Ponsky
Journal:  Gastrointest Endosc       Date:  2000-08       Impact factor: 9.427

2.  Practice guidelines for sedation and analgesia by non-anesthesiologists.

Authors: 
Journal:  Anesthesiology       Date:  2002-04       Impact factor: 7.892

3.  Endoscopic sedation in the United States: results from a nationwide survey.

Authors:  Lawrence B Cohen; Julie S Wecsler; John N Gaetano; Ariel A Benson; Kenneth M Miller; Valerie Durkalski; James Aisenberg
Journal:  Am J Gastroenterol       Date:  2006-05       Impact factor: 10.864

4.  Propofol alone titrated to deep sedation versus propofol in combination with opioids and/or benzodiazepines and titrated to moderate sedation for colonoscopy.

Authors:  Megan E VanNatta; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2006-10       Impact factor: 10.864

5.  A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect.

Authors:  V Billard; P L Gambus; N Chamoun; D R Stanski; S L Shafer
Journal:  Clin Pharmacol Ther       Date:  1997-01       Impact factor: 6.875

6.  Propofol for endoscopic sedation: A protocol for safe and effective administration by the gastroenterologist.

Authors:  Lawrence B Cohen; Amelia N Dubovsky; James Aisenberg; Kenneth M Miller
Journal:  Gastrointest Endosc       Date:  2003-11       Impact factor: 9.427

7.  A prospective safety study of a low-dose propofol sedation protocol for colonoscopy.

Authors:  Brian W Sipe; Mark Scheidler; Arthur Baluyut; Betty Wright
Journal:  Clin Gastroenterol Hepatol       Date:  2007-05       Impact factor: 11.382

8.  Modifications to the postanesthesia score for use in ambulatory surgery.

Authors:  J A Aldrete
Journal:  J Perianesth Nurs       Date:  1998-06       Impact factor: 1.084

9.  Sedation with propofol for interventional endoscopic procedures: a risk factor analysis.

Authors:  Till Wehrmann; Andrea Riphaus
Journal:  Scand J Gastroenterol       Date:  2008-03       Impact factor: 2.423

10.  An initial investigation of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy.

Authors:  Shawn C Chen; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2004-06       Impact factor: 10.864

View more
  6 in total

Review 1.  Bispectral Index Versus Standard Monitoring in Sedation for Endoscopic Procedures: A Systematic Review and Meta-Analysis.

Authors:  Se Woo Park; Hyuk Lee; Hongyup Ahn
Journal:  Dig Dis Sci       Date:  2015-11-03       Impact factor: 3.199

2.  Bispectral index-guided sedation in transfemoral transcatheter aortic valve implantation: a retrospective control study.

Authors:  Wei He; Rong-Rong Huang; Qing-Yu Shi; Xian-Bao Liu; Jian-An Wang; Min Yan
Journal:  J Zhejiang Univ Sci B       Date:  2017 Apr.       Impact factor: 3.066

3.  Effects of Bispectral Index-controlled Use of Magnesium on Propofol Consumption and Sedation Level in Patients Undergoing Colonoscopy.

Authors:  Hamit Yoldas; Isa Yildiz; Ibrahim Karagoz; Mustafa Sit; Muhammed Nur Ogun; Abdullah Demirhan; Murat Bilgi
Journal:  Medeni Med J       Date:  2019-12-26

Review 4.  Endoscopic sedation: from training to performance.

Authors:  Tae Hoon Lee; Chang Kyun Lee
Journal:  Clin Endosc       Date:  2014-03-31

5.  Effects of bispectral index monitoring as an adjunct to nurse-administered propofol combined sedation during colonoscopy: a randomized clinical trial.

Authors:  Jun Heo; Min Kyu Jung; Hyun Seok Lee; Chang Min Cho; Seong Woo Jeon; Sung Kook Kim; Young Hoon Jeon
Journal:  Korean J Intern Med       Date:  2016-02-26       Impact factor: 2.884

6.  Effect of depth of anesthesia on the phase lag entropy in patients undergoing general anesthesia by propofol: A STROBE-compliant study.

Authors:  Jae Hong Park; Sang Eun Lee; Eunsu Kang; Yei Heum Park; Hyun-Seong Lee; Soo Jee Lee; Dongju Shin; Gyu-Jeong Noh; Il Hyun Lee; Ki Hwa Lee
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.